Qrg Capital Management, Inc. Exelixis, Inc. Transaction History
Qrg Capital Management, Inc.
- $9.71 Trillion
- Q4 2024
A detailed history of Qrg Capital Management, Inc. transactions in Exelixis, Inc. stock. As of the latest transaction made, Qrg Capital Management, Inc. holds 58,928 shares of EXEL stock, worth $2.03 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
58,928
Previous 54,879
7.38%
Holding current value
$2.03 Million
Previous $1.42 Billion
37.79%
% of portfolio
0.02%
Previous 0.02%
Shares
6 transactions
Others Institutions Holding EXEL
# of Institutions
568Shares Held
250MCall Options Held
2.62MPut Options Held
1.95M-
Black Rock Inc. New York, NY33.5MShares$1.16 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.4MShares$1.02 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA25.4MShares$876 Million3.31% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.3MShares$528 Million0.8% of portfolio
-
State Street Corp Boston, MA11.4MShares$395 Million0.01% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $11.1B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...